CAPLIN POINT LABORATORIES LTD. - 524742 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Dinesh R GDesignation :- Company Secretary and Compliance Officer CAPLIN POINT LABORATORIES LTD. - 524742 - Shareholding for the Period Ended March 31, 2022
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2022. For more details, kindly Click here CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 CAPLIN POINT LABORATORIES LTD. - 524742 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window
Intimation - Closure of Trading Window CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015
CAPLIN POINT LABORATORIES LTD. - 524742 - Newspaper Advertisement - Disclosure Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Further to our letter dated February 3, 2022 on the outcome of the Board meeting, we enclose herewith the copy of newspaper advertisement with respect to financial results published today in the Financial Express (English Newspaper) and Maalai Malar (Tamil Newspaper). Kindly take the same on your records. 
Earnings Call for Q3FY22 of Caplin Point Laboratories
Conference Call with Caplin Point Laboratories Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.